by Suman Gupta
The 20th of November is observed as the World Hypoglycemia Day, honoring the birth anniversary of Dr. James Bertram Collip, the Canadian biochemist whose scientific breakthroughs were pivotal in the purification of insulin for clinical use and the first formal description of the phenomenon of hypoglycemia during early insulin research.
Born on 20th November 1892, Dr. Collip played a crucial role in transforming crude pancreatic extracts into a refined, safe, injectable form of insulin—making therapeutic use in humans possible. In the process of his biochemical work, he observed and documented dangerously low blood glucose reactions, laying the foundation for modern understanding of hypoglycemia as a clinical phenomenon and treatment-related complication informed Dr. Pranjali Shah & Dr. Shubhashree Patil from the Diabetes Research & Solutions (DRS) group.
“Since hypoglycemia is still a major impediment in achieving optimal glycemic control and improving the quality of lives of our people with diabetes, we commemorate World Hypoglycemia Day on Dr. Collip’s birthday to create more awareness, educate people on early detection, prevention and management of hypoglycemia,” said Dr Purvi Chawla – Consultant Diabetologist at Bhartiya Arogyanidhi Hospital, Juhu and Trustee, Mumbai Diabetes Care Foundation.
Why Hypoglycemia Still Matters
Even a century after insulin’s discovery, hypoglycemia remains:
A common adverse effect of insulin and insulin-secretagogues
A major cause of emergency hospital visits for Type 1 diabetes and Type 2 diabetes.
A barrier to optimal glycemic control due to fear of “lows”
A contributor to arrhythmias, cognitive impairment, and sudden mortality
Milder episodes affect confidence, quality of life, sleep, driving safety, productivity, and mental health.
Advancing Safety in Diabetes Care
Dr Rukaiya Shaikh and Dr Priyanka Rasne from DRS mention that –
The modern mission is zero occurrence of hypoglycemia and prevention of hypoglycemia driven by:
Continuous glucose monitoring (CGM) with alerts
Automated insulin delivery (AID) systems
Safer insulin analogues and non-hypoglycemia inducing therapies
Patient education, digital decision support, and data-driven care
Together, these innovations carry forward Dr. Collip’s legacy: not just enabling insulin therapy, but ensuring it is used safely.
About World Hypoglycemia Day :World Hypoglycemia Day commemorates the birth of Dr. James Collip (20 Nov 1892) and his foundational contributions to insulin science and the first clinical understanding of hypoglycemia. The day promotes research, awareness, public education, and safer therapeutic practices in diabetes care.
HOPE- Hypoglycemia Prevention and Education is an initiative towards creating more awareness about hypoglycemia and educating physicians and patients alike towards preventing and managing hypoglycemia effectively informs Dr Manoj Chawla, Consultant Diabetologist at PD Hinduja Khar and Trustee, Mumbai Diabetes Care Foundation
